FDA Inspection 1235504 — Admiron Life Sciences Pvt. Ltd.
The FDA completed an inspection of Admiron Life Sciences Pvt. Ltd. on February 9, 2024 in Paravada. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paravada (India)